Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly)

European Journal of Human Genetics

Volumn 20, Issue 4, 2012, Pages 480-482

  Reyes, Marcela ^a   Rothe, Hansjörg M ^b   Mattar, Pamela ^a   Shapiro, Warren B ^c   Cifuentes, Mariana ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b KLINIKUM COBURG   (Germany)

^c BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

calcium sensing receptor; cinacalcet; polymorphism

Indexed keywords

ARGININE; CALCIUM SENSING RECEPTOR; CINACALCET; FATTY ACID; GLYCEROL; GLYCINE; PARATHYROID HORMONE;

ADIPOCYTE; ADULT; ALLELISM; ARTICLE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; LIPOLYSIS; PARATHYROID CARCINOMA; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; RECEPTOR GENE; SECONDARY HYPERPARATHYROIDISM; SINGLE NUCLEOTIDE POLYMORPHISM; UREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CALCIUM; GENETIC VARIATION; HUMANS; HYPERCALCEMIA; MIDDLE AGED; NAPHTHALENES; POLYMORPHISM, GENETIC; RECEPTORS, CALCIUM-SENSING;

EID: 84858339603     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.221     Document Type: Article

References (19)

1. Brown EM, Gamba G, Riccardi D et al: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
2. Cifuentes M, Albala C, Rojas C: Calcium-sensing receptor expression in human adipocytes. Endocrinology 2005; 146: 2176-2179.
3. Cifuentes M, Rojas CV: Antilipolytic effect of calcium-sensing receptor in human adipocytes. Mol Cell Biochem 2008; 319: 17-21.
4. Nitta K: Possible link between metabolic syndrome and chronic kidney disease in the development of cardiovascular disease. Cardiol Res Pract 2011; 2011: 1-7.
5. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41: 733-741.
6. Weinberg JM: Lipotoxicity. Kidney Int 2006; 70: 1560-1566.
7. Egbuna OI, Brown EM: Hypercalcaemic and hypocalcaemic conditions due to calciumsensing receptor mutations. Best Pract Res Clin Rheumatol 2008; 22: 129-148.
8. Vezzoli G, Tanini A, Ferrucci L et al: Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002; 13: 2517-2523.
9. Scillitani A, Guarnieri V, De Geronimo S et al: Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 2004; 89: 5634-5638.
10. Corbetta S, Eller-Vainicher C, Filopanti M et al: R990G polymorphism of the calciumsensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 2006; 155: 687-692.
11. Yano S, Sugimoto T, Kanzawa M et al: Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 2000; 85: 317-323.
12. Rothe H, Shapiro WB, Sun WY et al: Calcium-sensing receptor gene polymorphism Arg990Gly influences the response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism. Per Med 2008; 5: 109-116.
13. Vezzoli G, Terranegra A, Arcidiacono T et al: R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 2007; 71: 1155-1162.
14. Rodbell M: Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-380.
15. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP: Kidney bone disease and mortality in CKD: Revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl 2010; 117: S10-S21.
16. Bagby SP: Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775-2791.
17. Axelsson J: The emerging biology of adipose tissue in chronic kidney disease: From fat to facts. Nephrol Dial Transplant 2008; 23: 3041-3046.
18. Cifuentes M, Albala C, Rojas CV: Differences in lipogenesis and lipolysis in obese and non-obese adult human adipocytes. Biol Res 2008; 41: 197-204.
19. He Y, Zhang H, Teng J, Huang L, Li Y, Sun C: Involvement of calcium-sensing receptor in inhibition of lipolysis through intracellular cAMP and calcium pathways in human adipocytes. Biochem Biophys Res Commun 2011; 404: 393-399.